CELL Technologies

CompanyCanada

CELL Technologies develops one asset, in phase 3 (Autologous Bone Marrow Aspirate Concentrate in knee osteoarthritis). Mostly cell therapy; based in Canada.

1
Asset
Furthest stage
Phase 3
1
Trial
1
Signal

Pipeline

1
  • Autologous Bone Marrow Aspirate Concentrate

    Autologous concentrated bone marrow cells delivering progenitor cells and anti-inflammatory factors for cartilage repair

    Phase 3, Cell therapy, knee osteoarthritis, musculoskeletal disease

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals1
  • Integrity notices2
  • Similar companies6

Intelligence